[Epidemiology]
- PMID: 20338718
- DOI: 10.1016/j.annfar.2010.02.010
[Epidemiology]
Abstract
In France, the incidence of PE is estimated to range between 1 and 3% in the nuliparous and between 0.5 and 1.5% in the multiparous women. Factors associated with the development of PE are of various types. Studies conducted on families affected by PE suggest the existence of a genetic component to the disease, even though the association between PE and certain genes, allotypes and polymorphisms are still under scrutiny. The hypotheses suggesting an immunological mechanism is supported by several arguments. Indeed, being nuliparous, changing partner, insemination with donor semen are factors associated with the development of PE whereas pre-exposition to the father's sperm bears protection. Some factors qualified as physiological are also associated with the occurrence of PE although no clear pathophysiological explanation can be put forward. These are being a mother of African descent, an increase in the mothers' age or herself being born prematurely. Some gestational incidents are also associated with the occurrence of PE: multiparity, a congenital defect affecting the foetus, UTI. Similarly, some pre-existing conditions of the mother are associated with PE, i.e. chronic hypertension, kidney disease, obesity and diabetes mellitus. Several well designed epidemiological studies confirm that tobacco consumption is itself associated with a 20 to 50% reduction in the development of PE, although being itself associated with an increase in other vascular gestational complications such as retroplacental haemorrhage and IUGR. Living conditions and stress, especially at work are also associated with the occurrence of PE. All these identified risk factors by far do not account for all the reported cases of PE and do not bear sufficient positive or negative predictive value.
Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Maternal metabolic syndrome, preeclampsia, and small for gestational age infancy.Am J Obstet Gynecol. 2015 Sep;213(3):370.e1-7. doi: 10.1016/j.ajog.2015.05.045. Epub 2015 May 22. Am J Obstet Gynecol. 2015. PMID: 26008179
-
Influence of pre-eclampsia on fetal growth.J Matern Fetal Neonatal Med. 2003 Mar;13(3):157-62. doi: 10.1080/jmf.13.3.157.162. J Matern Fetal Neonatal Med. 2003. PMID: 12820837
-
Risks of gestational diabetes and preeclampsia over the last decade in a cohort of Alberta women.J Obstet Gynaecol Can. 2013 Nov;35(11):986-994. doi: 10.1016/S1701-2163(15)30786-6. J Obstet Gynaecol Can. 2013. PMID: 24246398
-
Pre-Existing Diabetes Mellitus, Hypertension and KidneyDisease as Risk Factors of Pre-Eclampsia: A Disease of Theories and Its Association with Genetic Polymorphism.Int J Environ Res Public Health. 2022 Dec 12;19(24):16690. doi: 10.3390/ijerph192416690. Int J Environ Res Public Health. 2022. PMID: 36554576 Free PMC article. Review.
-
Cardiovascular events following pregnancy complicated by pre-eclampsia with emphasis on comparison between early- and late-onset forms: systematic review and meta-analysis.Ultrasound Obstet Gynecol. 2021 May;57(5):698-709. doi: 10.1002/uog.22107. Ultrasound Obstet Gynecol. 2021. PMID: 32484256
Cited by
-
Assessment of All-Cause Cancer Incidence Among Individuals With Preeclampsia or Eclampsia During First Pregnancy.JAMA Netw Open. 2021 Jun 1;4(6):e2114486. doi: 10.1001/jamanetworkopen.2021.14486. JAMA Netw Open. 2021. PMID: 34160606 Free PMC article.
-
Risk factors and poor prognostic factors of preeclampsia in Ibn Rochd University Hospital of Casablanca: about 401 preeclamptic cases.Pan Afr Med J. 2018 Dec 6;31:225. doi: 10.11604/pamj.2018.31.225.14401. eCollection 2018. Pan Afr Med J. 2018. PMID: 31447983 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources